Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Binuclear platinum (II)-diphosphonic acid coordination compound, preparation method and application thereof

A dual-nuclear platinum and complex technology, applied in the field of antitumor drugs, can solve the problems of large dosage, low activity, and many adverse reactions, and achieve the effects of small dosage, high intake, and few adverse reactions.

Active Publication Date: 2012-10-17
JIANGSU INST OF NUCLEAR MEDICINE
View PDF3 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0015] The technical problem to be solved by the present invention is that the activity of the platinum (II)-bisphosphonic acid complex described in the prior art is still low, the dosage is large, and the adverse reactions are many, and then a kind of high activity, small dosage, Binuclear platinum(II)-bisphosphonate complexes with few adverse reactions, especially fast non-targeted tissue clearance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Binuclear platinum (II)-diphosphonic acid coordination compound, preparation method and application thereof
  • Binuclear platinum (II)-diphosphonic acid coordination compound, preparation method and application thereof
  • Binuclear platinum (II)-diphosphonic acid coordination compound, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 Preparation of bisphosphonic acid derivatives

[0042]

[0043] Wherein, the preparation method of the bisphosphonic acid derivative of n=2, 3, 4 or 5 is as follows:

[0044]

[0045] (1) preparation of

[0046] Dissolve 0.1mol 1H-imidazole in 75ml of CH 2 Cl 2 , then add 0.15mol of KOH, 0.0835mol of K to the above solution 2 CO 3 And the tetrabutylammonium bromide of 0.002mol, stirred reaction 30min under room temperature, then in the above-mentioned solution, add the Br of 12.8ml dropwise (CH 2 ) n COOEt, reacted for 30min, then heated in an oil bath for 7h, filtered and washed to obtain

[0047] (2) preparation of

[0048] 60mmol of the prepared in step (1) Add 100ml of water, and then add 1ml of concentrated hydrochloric acid to it, react in an oil bath for 8h under stirring conditions, concentrate and crystallize to obtain

[0049] (3) preparation of

[0050] 20mmol of the prepared in step (2) Dissolve in 4.2ml of phosphoric ...

Embodiment 2

[0083] Example 2 Pt(en)(OSO 3 )(H 2 O) Preparation

[0084]

[0085] (1) Dissolve 1mmol of potassium chloroplatinite in 5mL of water, add 8mmol of excess KI aqueous solution dropwise under stirring conditions, react at 40°C for 30min, filter, then add 1mmol of ethylenediamine to the filtrate, and react at room temperature for 5h , filtered to obtain the precipitate, which is cis-[Pt(en)I 2 ], the productive rate is 94.94%;

[0086] (2) Add 1 mmol of cis-[Pt(en)I prepared in step (1) 2 ] was suspended in 20mL of water, and then 1mmol of silver sulfate was added thereto, reacted overnight at room temperature in the dark, filtered, and the filtrate was distilled under reduced pressure;

[0087] The vacuum distillation is carried out in two steps, the first step is vacuum distillation until the raffinate is 1 / 2 of the total volume of the original filtrate, the raffinate is filtered to obtain a new filtrate, and the new filtrate is subjected to vacuum distillation again to o...

Embodiment 3-1

[0088] Example 3-1 Preparation of binuclear platinum(II)-bisphosphonic acid complexes (bisphosphonate barium salt method)

[0089] In this embodiment, the bisphosphonic acid derivative with n=2 is selected, and the bisphosphonic acid derivative is referred to as IPrDP for short.

[0090] (1) Dissolve 0.1mmol of solid IPrDP in 5mL of water. At room temperature and under the protection of an inert gas, add 4ml of 0.025mmol / ml barium hydroxide aqueous solution dropwise into the above solution and stir for 20min to obtain white A suspension of a solid, wherein the white solid is the barium salt of IPrDP;

[0091] (2) Control the temperature of the suspension described in step (1) at 0-5°C, add 0.15 mmol of [Pt(en)(OSO 3 )(H 2 O)] dissolved in 5mL of water, dripped into the suspension described in step (1) under the protection of an inert gas (such as nitrogen), after reacting for 5h, separate the supernatant, and add Ba( Oh) 2 Adjust its pH to 4.0, continue to maintain stirr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
control rateaaaaaaaaaa
control rateaaaaaaaaaa
control rateaaaaaaaaaa
Login to View More

Abstract

The invention provides a binuclear platinum (II)-diphosphonic acid coordination compound, a preparation method and an application thereof, and belongs to the field of anti-cancer drugs. The binuclear platinum (II)-diphosphonic acid coordination compound has the structural formula shown in the description, wherein n is 2, 3, 4 or 5. The preparation method of the binuclear platinum (II)-diphosphonic acid coordination compound comprises the following steps: diphosphonic acid derivative and Pt(en)(OSO3)(H2O) are reacted under the function of Ba(OH)2 to obtain the binuclear platinum (II)-diphosphonic acid coordination compound. According to the compound, a link arm of C between diphosphonates is expanded; quinary aromatic amine (namely imidazole) is introduced in, so that at the initial usage stage of the coordination compound, the coordination compound has high intake in tumour cells and long residence time; and the aggregation concentration of the coordination compound in other non-targeted tissues is greatly reduced.

Description

technical field [0001] The invention relates to an antitumor drug, in particular to a binuclear platinum (II)-bisphosphonic acid complex, a preparation method and application thereof. Background technique [0002] Like other malignant tumors, osteosarcoma seriously threatens human health. Treatment options for osteosarcoma include surgery, radiation therapy, and systemic chemotherapy. Currently, patients with osteosarcoma generally take chemotherapy as the main clinical treatment. Platinum anticancer drugs are one of the most commonly used drugs in current combination chemotherapy, and have certain anticancer effects. So far, people have developed the first generation platinum anticancer drug cisplatin (cis-dichlorodiammine platinum), the second generation platinum anticancer drug carboplatin and the third generation platinum anticancer drug oxali platinum. Among them, cisplatin has serious drug resistance and side effects, such as nephrotoxicity and gastrointestinal tox...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07F19/00A61K31/675A61P35/00
Inventor 邱玲林建国陈丽萍罗世能程文姚君
Owner JIANGSU INST OF NUCLEAR MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com